Abstract
The effects of morphine sulfate, 300 μg/kg s.c., on the sleep of cats was studied by electroencephalographic techniques. In contrast to placebo experiments the animals were awake for approximately 6 h after administration of morphine; the return of regular sleep patterns occurred after about 11 h. A rebound increase in rapid eye movement (REM) sleep time and percentage was noted during the 11th through the 17th hour of the study. Sleep following manual sleep deprivation for 10 h showed a rebound increase in REM and non-rapid eye movement (NREM) sleep time. NREM sleep rebound after manual sleep deprivation exceeded that occurring after morphine. The alerting actions of morphine could be blocked by naloxone, 100 μg/kg s.c., for about 90 min. Naloxone alone increased REM sleep time and percentage. Single (84 mg/kg) or multiple (51 mg/kg for 4 injections) doses of dl-α-methyltyrosine i.p. did not block the alerting action or REM sleep rebound caused by morphine. 5-Hydrotryptophan (30 mg/kg) i.p. did not antagonize the alerting action of morphine.
Similar content being viewed by others
References
Blumberg, H., Wolf, P. S., Dayton, H. B.: Use of writhing test for evaluating analgesic activity of narcotic antagonists. Proc. Soc. exp. Biol. (N.Y.) 118, 763–766 (1965).
Delorme, F., Jeannerod, M., Jouvet, M.: Effets remarquables de la reserpine sur l'activité EEG phasique ponto-geniculo-occipitale. C. R. Soc. Biol. (Paris) 159, 900–903 (1965).
Dement, W. C.: The occurrence of low voltage, fast, electroencephalogram patterns during behavioral sleep in the cat. Electroenceph. clin. Neurophysiol. 10, 291–296 (1958).
Gaddum, J. H., Picarelli, Z. P.: Two kinds of tryptamine receptor. Brit. J. Pharmacol. 12, 323–328 (1957).
Green, H., Sawyer, J. L.: Biochemical-pharmacological studies with 5-hydroxytryptophan, precusor of serotonin. In: Progress in brain research. H. E. Himwich, W. A. Himwich, eds., vol. 8, pp. 150–167. Amsterdam: Elsevier 1964.
Gyermek, L., Bindler, E.: Blockade of the stimulant action of 5-hydroxytryptamine. J. Pharmacol. exp. Ther. 135, 344–348 (1962).
Jasinski, D. R., Martin, W. R., Haertzen, C. A.: The human pharmacology and abuse potential of N-allylnoroxymorphone (Naloxone). J. Pharmacol. exp. Ther. 157, 420–426 (1967).
Jewett, R. E.: Effect of promethazine on sleep stages in the cat. Exp. Neurol. 21, 368–382 (1968).
Jouvet, M.: Mechanisms of the states of sleep: A neuropharmacological approach. In: Sleep and altered states of consciousness. S. S. Kety, E. V. Evarts, and H. L. Williams, eds., pp. 86–126. Baltimore: Williams and Wilkins 1967.
Kay, D. C., Eisenstein, R. B., Jasinski, D. R.: Morphine effects on human REM state, waking state, and NREM sleep. Psychopharmacologia (Berl.) 14, 404–416 (1969).
Khazan, N., Weeks, J. R., Schroeder, L. A.: Electroencephalographic, electromyographic,and behavioral correlates during a cycle of self-maintained morphine addiction in the rat. J. Pharmacol. exp. Ther. 155, 521–531 (1967).
King, C. D., Jewett, R. E.: The effects of α-methyltyrosine on sleep and brain norepinephrine in cats. J. Pharmacol. exp. Ther. 177, 188–195 (1971).
Kiyono, S., Kawamoto, T., Sakakura, H., Iwama, K.: Effects of sleep deprivation upon the paradoxical phase of sleep in cats. Electroenceph. clin. Neurophysiol. 19, 34–40 (1965).
Koella, W., Feldstein, A., Czicman, J. S.: The effect of para-chlorophenylalanine on the sleep of cats. Electroenceph. clin. Neurophysiol. 25, 481–490 (1968).
Levitt, M., Spector, S., Udenfriend, S.: Formation of norepinephrine by the isolated heart. Fed. Proc. 23, 562 (1964).
Marantz, R., Rechtschaffen, A., Lovell, R. A., Whitehead, P. K.: Effect of alpha-methyltyrosine on the recovery from paradoxical sleep deprivation in the rat. In: Communications in behavioral biology, Part A. S. A. Weinstein, ed., vol. 2, pp. 161–64. New York: Academic Press 1968.
Maynert, E. W., Levi, R.: Stress-induced release of brain norepinephrine and its inhibition by drugs. J. Pharmacol. exp. Ther. 143, 90–95 (1964).
McClane, T. K., Martin, W. R.: Effects of morphine, nalorphine, cyclazocine, and naloxone on the flexor reflex. Int. J. Neuropharmacol. 6, 89–98 (1967).
McMillan, D. E., Wolf, P. S., Carchman, R. A.: Antagonism of the behavioral effects of morphine and methadone by narcotic antagonists in the pigeon. J. Pharmacol. exp. Ther. 175, 443–458 (1970).
Moore, K. E., Wright, P. F., Bert, J. K.: Toxicologic studies with α-methyltyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 155, 506–515 (1967).
Pearl, J., Harris, L. S.: Inhibition of writhing by narcotic antagonists. J. Pharmacol. exp. Ther. 154, 319–323 (1966).
Porter, C. C., Totario, J. A., Burcin, A., Wynosky, E. R.: The effects of the optical isomers of α-methyl-p-tyrosine upon brain and heart catecholamines in the mouse. Biochem. Pharmacol. 15, 583–590 (1966).
Siegel, S.: Nonparametric statistics for the behavioral sciences. New York: McGrawHill 1956.
Sterman, M. B., Knauss, T., Lehmann, D., Clemente, C. D.: Circadian sleep and waking patterns in the laboratory cat. Electroenceph. clin. Neurophysiol. 19, 509–517 (1965).
Udenfriend, S., Weissbach, H., Bogdanski, D. F.: Increase in tissue serotonin following administration of its precursor 5-hydroxytryptophan. J. biol. Chem. 224, 803–810 (1957).
—, Zaltzman-Nirenberg, P., Gordon, R., Spector, S.: Evaluation of the biochemical effects produced in vivo by inhibitors of three enzymes involved in norepinephrine biosynthesis. Molec. Pharmacol. 2, 95–105 (1966).
Vimont-Vicary, P., Jouvet-Mounier, D., Delorme, F.: Effets EEG et comportmentaux des privations de sommeil paradoxal chez le chat. Electroenceph. clin. Neurophysiol. 20, 439–449 (1966).
Vogt, M.: The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J. Physiol. (Lond.) 123, 451–481 (1954).
Author information
Authors and Affiliations
Additional information
A predoctoral fellow of Graduate Pharmacology Training Grant 2T1-GM179.
Rights and permissions
About this article
Cite this article
Echols, S.D., Jewett, R.E. Effects of morphine on sleep in the cat. Psychopharmacologia 24, 435–448 (1972). https://doi.org/10.1007/BF00402538
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00402538